The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mokari Atabak since 2026.
This trader's CIK number is 1678419.
At the time of last reporting, Mokari Atabak was the Chief Financial Officer of Corcept Therapeutics Inc. (stock ticker symbol CORT).
Also see all insider trading activities at Corcept Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | CORT | 0 | $0 | 40,000 | $2,800,000 | 40,000 | $770,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-06-01 | CORT | Sale | 40,000 | 70.00 | 2,800,000 |
| 2026-06-01 | CORT | Option Ex | 40,000 | 19.26 | 770,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mokari Atabak (Chief Financial Officer of Corcept Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.